Document is current
Any future updates will be listed below
-
Authors
Boutin, Julian https://orcid.org/0000-0001-9948-4129
Fayet, Sabrina
Marin, Victor https://orcid.org/0009-0000-7439-192X
Bergès, Camille https://orcid.org/0000-0002-7773-3689
Riandière, Maude
Toutain, Jérôme
Lamrissi-Garcia, Isabelle
Thibault, Chloé https://orcid.org/0000-0002-9420-4180
Cappellen, David https://orcid.org/0000-0002-9634-2595
Dabernat, Sandrine
Poulet, Arthur https://orcid.org/0000-0002-2020-9085
Francillette, Maëla
Droin, Nathalie https://orcid.org/0000-0002-6099-5324
Debeissat, Christelle
Brunet de la Grange, Philippe https://orcid.org/0000-0001-5002-6012
Moreau-Gaudry, François https://orcid.org/0000-0003-1813-3939
Bedel, Aurélie https://orcid.org/0000-0003-1226-1753
- License Information
-
More Information
Article History
Received: 29 March 2025
Accepted: 17 December 2025
First Online: 10 January 2026
Competing interests
: S.F., A.B., and F.M.G. declared a patent application EP23305760 filed on May 13th 2023 and claims the use of palbociclib to prevent genotoxicity induced by nuclease. The remaining authors declare no competing interests.
